DarioHealth Corp

Company Profile

DarioHealth Corp had its IPO on 2014-10-06 under the ticker symbol DRIO.

The company operates in the Healthcare sector and Diagnostics & Research industry. DarioHealth Corp has a staff strength of 241 employees.

Stock update

Shares of DarioHealth Corp opened at $3.03 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.94 - $3.1, and closed at $2.96.

This is a -3.27% slip from the previous day's closing price.

A total volume of 76,550 shares were traded at the close of the day’s session.

In the last one week, shares of DarioHealth Corp have slipped by -7.5%.

DarioHealth Corp's Key Ratios

DarioHealth Corp has a market cap of $109.66 million, indicating a price to book ratio of 1.1263 and a price to sales ratio of 3.4241.

In the last 12-months DarioHealth Corp’s revenue was $26.66 million with a gross profit of $14.01 million and an EBITDA of $-48453000. The EBITDA ratio measures DarioHealth Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, DarioHealth Corp’s operating margin was -200.08% while its return on assets stood at -28.34% with a return of equity of -63.48%.

In Q1, DarioHealth Corp’s quarterly earnings growth was a positive 0% while revenue growth was a negative 12.3%.

DarioHealth Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-2.91 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into DarioHealth Corp’s profitability.

DarioHealth Corp stock is trading at a EV to sales ratio of 2.5387 and a EV to EBITDA ratio of -1.0225. Its price to sales ratio in the trailing 12-months stood at 3.4241.

DarioHealth Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$108.01 million

Total Liabilities

$17.62 million

Operating Cash Flow

$-4362000.00

Capital Expenditure

$74000

Dividend Payout Ratio

0%

DarioHealth Corp ended 2024 with $108.01 million in total assets and $0 in total liabilities. Its intangible assets were valued at $108.01 million while shareholder equity stood at $72.03 million.

DarioHealth Corp ended 2024 with $830000.00 in deferred long-term liabilities, $17.62 million in other current liabilities, 3000.00 in common stock, $-298675000.00 in retained earnings and $41.64 million in goodwill. Its cash balance stood at $38.79 million and cash and short-term investments were $43.09 million. The company’s total short-term debt was $8,874,000 while long-term debt stood at $16.75 million.

DarioHealth Corp’s total current assets stands at $55.48 million while long-term investments were $0 and short-term investments were $4.30 million. Its net receivables were $5.28 million compared to accounts payable of $1.88 million and inventory worth $6.88 million.

In 2024, DarioHealth Corp's operating cash flow was $-4362000.00 while its capital expenditure stood at $74000.

Comparatively, DarioHealth Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.96

52-Week High

$7.69

52-Week Low

$3.13

Analyst Target Price

$9.8

DarioHealth Corp stock is currently trading at $2.96 per share. It touched a 52-week high of $7.69 and a 52-week low of $7.69. Analysts tracking the stock have a 12-month average target price of $9.8.

Its 50-day moving average was $3.43 and 200-day moving average was $4.12 The short ratio stood at 11.48 indicating a short percent outstanding of 0%.

Around 1297.5% of the company’s stock are held by insiders while 3618.2% are held by institutions.